Abstract
Real-world Switching Rates of Atogepant Are Lower than CGRP Monoclonal Antibodies (mAbs) in Patients with Migraine Using Claims Database (P4-12.008)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have